S
Senti Biosciences D
D
SNTI
2.14000
USD
-0.19
(-8.15%)
مغلق
حجم التداول
16,095
الربح لكل سهم
0
العائد الربحي
-
P/E
6
حجم السوق
55,813,637
العنوان: Senti Biosciences Inc.
القطاع: Healthcare
الصناعة: Biotechnology
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.